Health Trials

About this trial

This multicenter, prospective, observational study aims to develop and validate an EIT-based prognostic model for ARDS. By focusing on the pathophysiological characteristics of ARDS and the causes of ventilator-induced lung injury, the investigators intend to establish a prognostic model that reveals lung injury and heterogeneity, enabling risk stratification and guiding individualized treatment.

Eligibility criteria

Qualifiers

Meet the new 2023 ARDS global definition;

Age 18-80 years

Disqualifiers

Expected death within 24 hours of screening;

Metastatic cancer (active malignancy with distant metastases);

Severe psychiatric disorders;

Pregnancy or postpartum status;

Trial design

Treatments tested in this trial

  • Not applicable- observational study

Treatment groups

625 Participants
are divided into 2 treatment groups

Locations

4
Department of Critical Care Medicine, Guangdong Provincial People's Hospital GuangzhouGuangdong, China
Department of Critical Care Medicine, Renmin Hospital of Wuhan University WuhanHubei, China
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China Department of WuhanHubei, China
Department of Emergency, Zhongshan Hospital, Fudan University ShanghaiShanghai Municipality, China

Sponsors and collaborators

XiaoJing Zou,MD

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sponsor institution

Source ClinicalTrials.gov